XENA, why do you think that I am so angry with the (lack of) progress with this drug? I know several who struggle/suffer with a CNS condition. I don’t get this same sense of urgency from our CEO.
I pity those who are relying on DM to deliver an approval. So far, he has fallen well short—other than enriching himself.
Direct your consternation at where it belongs—our CEO.
Market Data 
Markets 
AI
